Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up

In: Fertility and Sterility · 1992 · vol. 57(3) , pp. 514–522 · doi:10.1016/s0015-0282(16)54893-6 · W4254562704
article OA: closed CC0 ⤵ 65 in-corpus citations
AI-generated summary by gemini-2.5-flash-lite, 2026-06-08

This trial compared the efficacy and safety of nafarelin to danazol for endometriosis treatment, with follow-up extending to one year.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (50)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-12T06:43:03.944938+00:00
License: CC0 · commercial use OK